Masaki Tomiyama
Nessuna posizione attualmente
Profilo
Masaki Tomiyama served as an Executive Director at C&O Pharmaceutical Technology (Holdings) Ltd.
and as a Deputy General Manager-Overseas Business Division at Shionogi & Co., Ltd.
He obtained an undergraduate degree from Doshisha University in 1992.
Precedenti posizioni note di Masaki Tomiyama
| Società | Posizione | Fine |
|---|---|---|
| SHIONOGI & CO., LTD. | Corporate Officer/Principal | - |
C&O Pharmaceutical Technology (Holdings) Ltd.
 C&O Pharmaceutical Technology (Holdings) Ltd. Pharmaceuticals: MajorHealth Technology C&O Pharmaceutical Technology (Holdings) Ltd. manufactures and distributes pharmaceutical products. It offers anti-infection and gastrointestinal drugs, drugs for ageing adults, and specialized drugs. The firm's products are used for various indications, such as skin soft tissues infections, analgesic and antipyretic, indigestion or gastro esophageal reflux disorder, respiratory tract infections, sinusitis, hypertension and migraine. The company was founded by Lai Chi Ma and Bin Gao in 2003 and is headquartered in Hong Kong. | Direttore/Membro del Consiglio | - |
Formazione di Masaki Tomiyama
| Doshisha University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| SHIONOGI & CO., LTD. | Health Technology |
| Aziende private | 1 |
|---|---|
C&O Pharmaceutical Technology (Holdings) Ltd.
C&O Pharmaceutical Technology (Holdings) Ltd. Pharmaceuticals: MajorHealth Technology C&O Pharmaceutical Technology (Holdings) Ltd. manufactures and distributes pharmaceutical products. It offers anti-infection and gastrointestinal drugs, drugs for ageing adults, and specialized drugs. The firm's products are used for various indications, such as skin soft tissues infections, analgesic and antipyretic, indigestion or gastro esophageal reflux disorder, respiratory tract infections, sinusitis, hypertension and migraine. The company was founded by Lai Chi Ma and Bin Gao in 2003 and is headquartered in Hong Kong. | Health Technology |
- Borsa valori
- Insiders
- Masaki Tomiyama
